Clinical studies recruiting near Cardiff

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · University Hospital of Wales · Pfizer · NCT05020236 Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Velindre Cancer Centre · Pfizer · NCT07028853 A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Phase 3 · Site GB44005 · Astellas Pharma Global Development, Inc. · NCT05970172 Methods of T Cell Depletion Trial (MoTD)
Phase 2 · University Hospital of Wales · University of Birmingham · NCT04888741 STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06960213 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Velindre NHS Trust - Velindre Cancer Centre · Hoffmann-La Roche · NCT06793215 Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Phase 1/Phase 2 · University Hospital of Wales · CellCentric Ltd. · NCT04068597 Home-Based Transcranial Direct Current Stimulation In Major Depressive Disorder (HOME)
NA · Cardiff and Vale Health Board · King's College London · NCT07228468 A Study Assessing HMB-002 in Participants With Von Willebrand Disease
Phase 1/Phase 2 · University Hospital of Wales · Hemab ApS · NCT06754852 A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Sele
NA · Alimentiv Inc. · NCT07363044 A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy
Phase 2 · University Hospital of wales · University of Leicester · NCT04663204 Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer
Phase 2 · Velindre Cancer Centre · Cambridge University Hospitals NHS Foundation Trust · NCT05093231 Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers
NA · University Hospital of Wales · University College, London · NCT05604963 A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Dia
Phase 3 · University Hospital of Wales · Eli Lilly and Company · NCT07222332 A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorecta
Phase 1 · Velindre Cancer Centre · Hoffmann-La Roche · NCT04929223 A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Phase 3 · University Hospital of Wales · Hoffmann-La Roche · NCT07416526 PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Dam
Phase 2 · Velindre Cancer Center at Velinde Hospital · Institute of Cancer Research, United Kingdom · NCT03740893 Understanding Inflammation, InFection and Interventions in Severe Exacerbations of Cystic Fibrosis
Phase N/A · Cardiff and Vale University Health Board · Alexander Horsley · NCT07484607 Capillary OGTT Study
Phase N/A · Noah's Ark Childrens Hospital for Wales · University of Oxford · NCT06815081 International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)
Phase 3 · Velindre NHS Trust · Institute of Cancer Research, United Kingdom · NCT02305654 SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Phase 2 · Noahs Ark Childrens Hospital for Wales · SAb Biotherapeutics, Inc. · NCT07187531 A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes
Phase N/A · University Hospital of Wales · Bristol-Myers Squibb · NCT05489705 Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT03955445 A Global Prospective Observational Registry of Patients With Pompe Disease
Phase N/A · University Hospital of Wales, Cardiff · Amicus Therapeutics · NCT06121011 Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesop
Phase 3 · Velindre Cancer Centre · Daiichi Sankyo · NCT06731478 PASS of Xromi Comparing Safety and Effectiveness in Children Under 2 Years With Sickle Cell Disease [PRECISE PASS]
Phase N/A · Noah's Ark Children's Hospital for Wales · Nova Laboratories Limited · NCT06923111 A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alon
Phase 1/Phase 2 · Velindre Cancer Centre · BioNTech SE · NCT07070232 A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
Phase 3 · University Hospital of Wales · Hoffmann-La Roche · NCT07416604 DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adul
Phase 2/Phase 3 · Velindre Cancer Centre · Cancer Research UK · NCT05786716

Look up another city

Look up another condition